过敏性鼻炎及其对喘的影响 (ARIA) 类别在MASK-air用户中
B Sousa-Pinto1,2, M Savouré3, R J Vieira1,2
1MEDCIDS - Department of Community Medicine, Information and Health Decision Sciences; Faculty of Medicine, University of Porto, Porto, Portugal.
Journal of investigational allergology & clinical immunology
|January 23, 2025
概括
持续的过敏性鼻炎与喘的联系比鼻炎的严重程度更强烈. 伴随性喘通常会导致ARIA分类中的鼻炎控制较差.
科学领域:
- 过敏和免疫学的过敏和免疫学.
- 呼吸系统药物 呼吸系统药物
- 现实世界的证据研究研究.
背景情况:
- 过敏性鼻炎及其对喘的影响 (ARIA) 准则根据持续时间 (间歇性/持续性) 和严重程度 (轻度/中度至严重) 分类鼻炎.
- 了解ARIA类内的表型差异对于管理伴随性喘至关重要.
研究的目的:
- 在现实环境中评估ARIA分类频率.
- 为了比较ARIA类之间的表型差异.
- 为了研究鼻炎和并发性喘之间的关联.
主要方法:
- 使用MASK-air®应用数据从2273名用户使用至少3个月的数据进行横截面研究.
- 评估ARIA类频率,鼻炎症状 (VAS),药物使用和喘并发症.
- 在患有喘和没有喘的患者中比较鼻炎控制.
主要成果:
- 88.1%的人患有中度至重度,而50.3%的人患有持续性鼻炎.
- 间歇性喘的概率为35.7%,持续性鼻炎的概率为48.5%.
- 患有并发性喘的患者表现出更高的症状得分和更频繁的药物使用.
结论:
- 鼻炎的持续性,而不是严重性,与喘更密切相关.
- 并发性喘可能与ARIA类的鼻炎控制较差有关.
相关概念视频
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma: Pathogenesis and Management
346
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
346
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
Drugs Used in Lower Respiratory Disorders: Overview
349
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
349
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
236
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
236


